Meta-analysis of Molteno glaucoma implants and Ahmed glaucoma valves: insights into efficacy and safety for complex glaucoma.

Ahmed glaucoma valve Molteno glaucoma implant glaucoma glaucoma—surgery surgery

Journal

Frontiers in ophthalmology
ISSN: 2674-0826
Titre abrégé: Front Ophthalmol (Lausanne)
Pays: Switzerland
ID NLM: 9918419176106676

Informations de publication

Date de publication:
2023
Historique:
received: 04 10 2023
accepted: 16 11 2023
medline: 10 7 2024
pubmed: 10 7 2024
entrez: 10 7 2024
Statut: epublish

Résumé

Glaucoma is a leading cause of irreversible blindness globally and for decades, Molteno and Ahmed glaucoma implants, operating on different mechanisms, have been used to treat complicated glaucoma with varying success. To assess the safety and efficacy of the Molteno glaucoma implant (MGI) versus the Ahmed glaucoma valve (AGV) in patients with complicated glaucoma. We comprehensively searched PubMed, Google Scholar, Cochrane Library and Science Direct) from inception till July 2023 and studies comparing patients with MGI and those with AGV in patients with complicated glaucoma. The primary outcome was intra-ocular pressure reduction at different time intervals. Secondary outcomes included surgical success rate, hypertensive phase, anti-glaucoma medication (AGM) and total complications. In this meta-analysis, four studies were included with a patient population of 257 with refractory, neovascular or advanced uncontrolled glaucoma. Postoperative intra-ocular pressure reduction did not show significant difference between the two groups (MD: -1.34, 95% CI [-2.78, 0.09]). From the secondary outcomes, surgical success rate (RR: 0.88, 95% CI [0.51,1.53]), hypertensive phase (RR: 0.74, 95% CI [0.39,1.40]) were insignificant. Postoperative anti-glaucoma medication (MD: -0.07, 95% CI [-0.79, -0.65] and total complications (RR:1.36, 95% CI [1.07, 1.72]) were significant. No significant difference was observed between the patients with MGI and AGV for the primary outcome. From the secondary outcome, AGV was associated with reduced anti-glaucoma medication use and significantly lowered the number of complications. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=475539, identifier CRD42023475539.

Sections du résumé

Background UNASSIGNED
Glaucoma is a leading cause of irreversible blindness globally and for decades, Molteno and Ahmed glaucoma implants, operating on different mechanisms, have been used to treat complicated glaucoma with varying success.
Objective UNASSIGNED
To assess the safety and efficacy of the Molteno glaucoma implant (MGI) versus the Ahmed glaucoma valve (AGV) in patients with complicated glaucoma.
Methods UNASSIGNED
We comprehensively searched PubMed, Google Scholar, Cochrane Library and Science Direct) from inception till July 2023 and studies comparing patients with MGI and those with AGV in patients with complicated glaucoma. The primary outcome was intra-ocular pressure reduction at different time intervals. Secondary outcomes included surgical success rate, hypertensive phase, anti-glaucoma medication (AGM) and total complications.
Results UNASSIGNED
In this meta-analysis, four studies were included with a patient population of 257 with refractory, neovascular or advanced uncontrolled glaucoma. Postoperative intra-ocular pressure reduction did not show significant difference between the two groups (MD: -1.34, 95% CI [-2.78, 0.09]). From the secondary outcomes, surgical success rate (RR: 0.88, 95% CI [0.51,1.53]), hypertensive phase (RR: 0.74, 95% CI [0.39,1.40]) were insignificant. Postoperative anti-glaucoma medication (MD: -0.07, 95% CI [-0.79, -0.65] and total complications (RR:1.36, 95% CI [1.07, 1.72]) were significant.
Conclusion UNASSIGNED
No significant difference was observed between the patients with MGI and AGV for the primary outcome. From the secondary outcome, AGV was associated with reduced anti-glaucoma medication use and significantly lowered the number of complications.
Systematic review registration UNASSIGNED
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=475539, identifier CRD42023475539.

Identifiants

pubmed: 38983029
doi: 10.3389/fopht.2023.1307439
pmc: PMC11182311
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Pagination

1307439

Informations de copyright

Copyright © 2023 Raja, Bhimani, Alim Ur Rahman, Salman, Saeed Shaikh, Raja, Zafar Sayeed, Feroze and Ahmed.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Adarsh Raja (A)

Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.

Sunaina Bhimani (S)

Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Hafsah Alim Ur Rahman (H)

Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Madiha Salman (M)

Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Afrah Saeed Shaikh (A)

Ziauddin Medical College, Ziauddin University, Karachi, Pakistan.

Sandesh Raja (S)

Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Bushra Zafar Sayeed (B)

Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

Ahsan Feroze (A)

Department of Medicine, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.

Muhammad Ahmed (M)

Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.

Classifications MeSH